
Protalix BioTherapeutics, Inc.
PLXNYSECIK 1006281HealthcareFiscal year ends Dec 31
Reports and events: 399 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2017-04-1207:39 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001144204-17-020074 |
| 2017-03-1616:21 ET | DEF 14A | Proxy statementPeriod 2017-04-12 | 0001144204-17-015102 |
| 2017-03-1616:08 ET | 10-K | Annual reportPeriod 2016-12-31 | 0001144204-17-015083 |
| 2017-03-1608:08 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001144204-17-014889 |
| 2017-02-1616:31 ET | 8-K | 7.01 Regulation FD disclosure | 0001144204-17-009587 |
| 2017-02-1417:39 ET | 8-K | 5.08 Item not in the standard list; 9.01 Financial statements and exhibits | 0001144204-17-009041 |
| 2017-02-1417:20 ET | 8-K | 5.08 Item not in the standard list; 9.01 Financial statements and exhibits | 0001144204-17-009023 |
| 2017-01-0906:11 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001144204-17-001203 |
| 2017-01-0307:39 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001144204-17-000033 |
| 2016-12-2707:38 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001144204-16-141308 |
| 2016-12-1407:39 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001144204-16-139314 |
| 2016-12-0717:26 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001144204-16-138423 |
| 2016-12-0218:45 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001144204-16-137521 |
| 2016-11-3008:01 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001144204-16-137103 |
| 2016-11-2216:18 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001144204-16-135929 |
| 2016-11-0916:32 ET | 10-Q | Quarterly reportPeriod 2016-09-30 | 0001144204-16-132819 |
| 2016-11-0908:09 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001144204-16-132568 |
| 2016-10-2507:40 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001144204-16-129272 |
| 2016-08-1007:39 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001144204-16-117891 |
| 2016-08-0816:51 ET | 10-Q | Quarterly reportPeriod 2016-06-30 | 0001144204-16-117287 |
| 2016-08-0816:40 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001144204-16-117272 |
| 2016-07-0707:36 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001144204-16-111871 |
| 2016-07-0117:04 ET | DEF 14A | Proxy statementPeriod 2016-08-07 | 0001144204-16-111273 |
| 2016-06-0709:34 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001144204-16-107222 |
| 2016-06-0607:08 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001144204-16-106902 |
| 2016-05-0916:32 ET | 10-Q | Quarterly reportPeriod 2016-03-31 | 0001144204-16-099933 |
| 2016-05-0907:16 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001144204-16-099713 |
| 2016-04-2217:00 ET | 10-K/A | Annual report, amendedPeriod 2015-12-31 | 0001144204-16-095858 |
| 2016-04-0817:00 ET | 8-K | 8.01 Other events | 0001144204-16-093507 |
| 2016-04-0117:00 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001144204-16-092335 |
| 2016-03-0816:31 ET | 10-K | Annual reportPeriod 2015-12-31 | 0001144204-16-086642 |
| 2016-03-0807:38 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001144204-16-086517 |
| 2016-03-0307:06 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001144204-16-085676 |
| 2016-01-0416:30 ET | 8-K | 5.08 Item not in the standard list | 0001144204-16-073802 |
| 2015-12-1116:30 ET | 10-Q/A | Quarterly report, amendedPeriod 2015-09-30 | 0001144204-15-070554 |
| 2015-11-2316:05 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001144204-15-067493 |
| 2015-11-1607:14 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001144204-15-065519 |
| 2015-11-0916:42 ET | 10-Q | Quarterly reportPeriod 2015-09-30 | 0001144204-15-063825 |
| 2015-11-0916:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001144204-15-063756 |
| 2015-10-1907:34 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001144204-15-059866 |
| 2015-10-1317:29 ET | 8-K | 1.01 Entry into a material agreement; 2.02 Results of operations; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001144204-15-059259 |
| 2015-10-0116:30 ET | DEF 14A | Proxy statementPeriod 2015-11-08 | 0001144204-15-057696 |
| 2015-09-0907:06 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001144204-15-054121 |
| 2015-08-1016:50 ET | 10-Q | Quarterly reportPeriod 2015-06-30 | 0001144204-15-047801 |
| 2015-08-1016:37 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001144204-15-047786 |
| 2015-05-0716:48 ET | 10-Q | Quarterly reportPeriod 2015-03-31 | 0001144204-15-028431 |
| 2015-05-0716:39 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001144204-15-028413 |
| 2015-03-1216:45 ET | 10-K | Annual reportPeriod 2014-12-31 | 0001144204-15-015672 |
| 2015-03-1216:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001144204-15-015665 |
| 2015-02-1207:38 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001144204-15-008141 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 10, 2026, 16:48 ET. Listed shows no prices and gives no investment advice.